# US 2022/0025442 A1 · Systems and methods for determining nucleic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0025442 A1
- Document ID: US20220025442A1
- Status: Published application
- Kind: A1
- Application number: 17/374,000
- Filed: 2021-07-13
- Published: 2022-01-27
- Earliest claimed: 2014-07-30
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: Xiaowei Zhuang; Kok-Hao Chen; Alistair Boettiger; Jeffrey R. Moffitt; Siyuan Wang
- Web page: https://patentgrep.com/patent/US20220025442A1

## CPC

- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C07H 21/02: with ribosyl as saccharide radical
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/1093: {General methods of preparing gene libraries, not provided for in other subgroups}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/6844: Nucleic acid amplification reactions
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B 25/20: Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
- G16B 40/10: Signal processing, e.g. from mass spectrometry [MS] or from PCR
- G16C 20/10: Analysis or design of chemical reactions, syntheses or processes
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6841: In situ hybridisation
- C12Q 1/6869: Methods for sequencing
- G06N 7/01: Probabilistic graphical models, e.g. probabilistic networks
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS

## Abstract

The present invention generally relates to systems and methods for imaging or determining nucleic acids, for instance, within cells. In some embodiments, the transcriptome of a cell may be determined. Certain embodiments are directed to determining nucleic acids, such as mRNA, within cells at relatively high resolutions. In some embodiments, a plurality of nucleic acid probes may be applied to a sample, and their binding within the sample determined, e.g., using fluorescence, to determine locations of the nucleic acid probes within the sample. In some embodiments, codewords may be based on the binding of the plurality of nucleic acid probes, and in some cases, the codewords may define an error-correcting code to reduce or prevent misidentification of the nucleic acids. In certain cases, a relatively large number of different targets may be identified using a relatively small number of labels, e.g., by using various combinatorial approaches.

## Claims

### Claim at position 1

1-94. (canceled)

### Claim 95

A composition, comprising:
a plurality of nucleic acid probes, each comprising a first portion comprising a target sequence and a plurality of read sequences, wherein the plurality of read sequences are distributed on the plurality of nucleic acid probes so as to define an error-correcting code.

### Claim 96 (depends on 95)

The composition of claim 95, wherein the plurality of nucleic acid probes defines a code space with a Hamming distance of at least 2 or at least 3.

### Claim 97

(canceled)

### Claim 98 (depends on 96)

The composition of claim 96, wherein the code is a Hamming(7, 4) code, a Hamming(15, 11) code, a Hamming(31, 26) code, a Hamming(63, 57) code, or a Hamming(127, 120) code.

### Claim 99 (depends on 95)

The composition of claim 95, wherein the code is a SECDED code.

### Claim at position 7

100-101. (canceled)

### Claim 102 (depends on 99)

The composition of claim 99, wherein the code is a SECDED (8, 4) code, a SECDED (16, 4) code, SECDED (16, 11) code, a SECDED (22, 16) code, a SECDED (39, 32) code, or a SECDED (72, 64) code.

### Claim 103

(canceled)

### Claim 104 (depends on 99)

The composition of claim 99, wherein the code is MHD4 code or MHD2 code.

### Claim 105

(canceled)

### Claim 106 (depends on 95)

The composition of claim 95, wherein the plurality of nucleic acid probes comprises no more than 100, no more than 64, no more than 32, no more than 16, or no more than 8, no more than 6, no more than 4, or no more than 2 possible read sequences.

### Claim at position 13

107-110. (canceled)

### Claim 111 (depends on 95)

The composition of claim 95, wherein
(a) the target sequence of the plurality of nucleic acid probes has an average length of between 10 and 200 nucleotides;
(b) the plurality of read sequences have an average length of between 5 nucleotides and 50 nucleotides;
(c) the plurality of nucleic acid probes have an average length of between 10 and 300 nucleotides; or
(d) combinations of one or more of (a)-(c).

### Claim at position 15

112-116. (canceled)

### Claim 117 (depends on 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116)

The composition of any one of claims 95-116, wherein at least some of the plurality of nucleic acid probes comprise DNA, RNA, PNA, LNA, or combinations thereof.

### Claim at position 17

118-121. (canceled)

### Claim 122

A method, comprising:
associating a plurality of targets with a plurality of target sequences and a plurality of codewords, wherein the codewords comprise a number of positions and values for each position, and the codewords form an error-checking and/or error-correcting code space;
associating a plurality of distinguishable read sequences with the plurality of codewords such that each distinguishable read sequence represents a value of a position within the codewords; and
forming a plurality of nucleic acid probes, each comprising a target sequence and one or more read sequences.

### Claim 123 (depends on 122)

The method of claim 122, wherein the code space has a Hamming distance of at least 2.

### Claim 124 (depends on 122)

The method of any one of claim 122, wherein the plurality of targets comprise RNA.

### Claim 125

(canceled)

### Claim 126 (depends on 122)

A method, comprising:
exposing nucleic acid probes formed using the method of claim 122 to a sample including a plurality of targets;
sequentially determining binding of each of a plurality of secondary nucleic probes to the nucleic acid probes within the sample;
determining sample codewords comprising a pattern of bindings of the plurality of secondary nucleic probes to the nucleic acid probes; and
matching the sample codewords to the codewords to determining targets within the sample.

### Claim 127 (depends on 126)

The method of claim 126, wherein at least some of the plurality of secondary nucleic probes is able to bind to a read sequence of a nucleic acid probe.

### Claim 128 (depends on 127)

The method of claim 127, wherein at least some of the plurality of secondary nucleic probes is able to specifically bind to only one read sequence.

### Claim 129 (depends on 125)

The method of claim 125, wherein if no match is found between a valid codeword and the sample codeword, applying error correction to the sample codeword to identify a matched codeword.

### Claim 130 (depends on 125)

The method of claim 125, wherein at least some of the secondary nucleic acid probes each comprise a signaling entity.

### Claim 131 (depends on 130)

The method of claim 130, comprising imaging the signaling entity to determine binding of the plurality of secondary nucleic probes within the sample.

### Claim 132 (depends on 131)

The method of claim 131, comprising imaging the signaling entity using a super-resolution imaging technique.

### Claim at position 29

133-134. (canceled)

### Claim 135 (depends on 125)

The method of claim 125, comprising determining binding of the plurality of secondary nucleic probes within the sample at a resolution better than 100 nm.

### Claim at position 31

136-176. (canceled)
